VEDOLIZUMAB LEVELS IN MOTHERS AND NEWBORNS, CLEARANCE IN NEONATES, SUSCEPTIBILITY TO INFECTION, AND ACHIEVEMENT OF DEVELOPMENTAL MILESTONES

Mette Julsgaard  ¹     Daniel C. Baumgart  ²     Simon Mark Dahl Jørgensen  ²     Mette Mejlby Hansen  ²     Anne Grosen  ²     jens kjeldsen  ³     Heidi Gram Sørensen  ⁴     Lone Larsen  ⁵     Signe Wildt  ⁶     Petra Weimers  ⁷     Kent Valentin Haderslev  ⁸     Ida Vind  ⁹     Lise Svenningsen  ¹⁰     Jørn Brynskov  ¹¹     Søren Lyhne  ¹²     Thea Vestergaard  ¹²     Christian Lodberg Hvas  ¹²     Jens Kelsen  ^12    
1 Aarhus University Hospital, Aarhus, Denmark
² University of Alberta, Edmonton, Canada
³ Odense University Hospital, Odense, Denmark
⁴ Herning Hospital, Herning, Denmark
⁵ Aalborg University Hospital, Aalborg, Denmark
⁶ Koege Hospital, University of Copenhagen, Koege, Denmark
⁷ North Zealand University Hospital, Frederikssund, Denmark
⁸ Rigshospitalet, Copenhagen, Denmark
⁹ Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
¹⁰ Horsens Hospital, Horsens, Denmark
¹¹ Herlev Hospital, University of Copenhagen, Herlev, Denmark
¹² Randers Hospital, Randers, Denmark

Topic
IBD, Immunology, Paediatrics, Primary Care

Session
Special situations in IBD

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)